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Serotonin is a major neurotransmitter in the central nervous system (CNS). Dysregulation of serotonin transmission in the CNS
is reported to be related to different psychiatric disorders in humans including depression, impulsive aggression and anxiety
disorders. The most frequently prescribed antidepressants and anxiolytics target the serotonergic system. However, these
drugs are not effective in 20–30% of cases. The causes of this failure as well as the molecular mechanisms involved in the origin
of psychological disorders are poorly understood. Biosynthesis of serotonin in the CNS is initiated by tryptophan hydroxylase 2
(TPH2). In this study, we used Tph2-deﬁcient (Tph2
 / ) mice to evaluate the impact of serotonin depletion in the brain on mouse
behavior. Tph2
 /  mice exhibited increased depression-like behavior in the forced swim test but not in the tail suspension test.
In addition, they showed decreased anxiety-like behavior in three different paradigms: elevated plus maze, marble burying and
novelty-suppressed feeding tests. These phenotypes were accompanied by strong aggressiveness observed in the resident–
intruder paradigm. Despite carrying only one copy of the gene, heterozygous Tph2
þ/  mice showed only 10% reduction in brain
serotonin, which was not sufﬁcient to modulatebehavior in the tested paradigms. Our ﬁndings provide unequivocal evidence on
the pivotal role of central serotonin in anxiety and aggression.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine that
has a dual role, working both as an autacoid in the periphery
and as a neurotransmitter in the brain. Synthesis of 5-HT
starts with the conversion of the essential amino acid
tryptophan (Trp) to 5-hydroxytryptophan (5-HTP) by trypto-
phan hydroxylase (TPH). In the second step, 5-HTP is
decarboxylated to 5-HT by the aromatic amino acid dec-
arboxylase. The discovery of a second Tph gene unraveled
the existence of two independent 5-HT systems in verte-
brates — peripheral and central — controlled by TPH1 and
TPH2, respectively.
1,2 Although TPH1 is mainly expressed in
the gut and is responsible for the synthesis of peripheral
serotonin, TPH2 is expressed in the neurons of the raphe ´
nuclei in the brainstem
2–4 and in myenteric neurons in the
gut,
5 but not in other peripheral organs such as the lung,
heart, kidney or liver.
6,7 Mice lacking TPH2 (Tph2
 / , Tph2-
deﬁcient mice) were recently generated by our group
8 and
others.
3,9–12 Tph2
 /  mice exhibit only minute amounts of
brain serotonin, but normal formation and differentiation of
serotonergic neurons.
3,8 The level of peripheral serotonin
was unchanged in these mice, although it did not restore the
brain 5-HT levels as serotonin cannot cross the blood brain
barrier. Tph2
 /  mice display normal size and no obvious
abnormalities at birth, but exhibit growth retardation during
earlypostnatallife.However,Tph2
 / micecatchupthebody
weight and at the age of 3 months are not any more
distinguishable from wild-type mice. Moreover, these mice
exhibit altered thermoregulation and respiratory control, and
impaired maternal care.
8
Ithasbeenpostulatedthatreductioninbrainserotoninleads
to increased depressive and aggressive behaviors. In humans
different polymorphisms of genes involved in the central
serotonin synthesis and transmission are associated with
various psychological abnormalities such as depression,
13–17
anxiety disorders
18 and aggression.
19,20 Moreover, differ-
ences in the level of serotonin or its metabolite, 5-hydroxy-
indoleacetic acid (5-HIAA), in the cerebrospinal ﬂuid
have been found in patients with depression
21–23 and destruc-
tive behaviors, such as aggression, violence and impulsiv-
ity.
22,24–26 Further elucidation of mechanisms by which central
serotonin is involved in depression and anxiety disorders is
required for the improvement of existing medical treatment.
In this study, we evaluated the rate of serotonin synthesis in
the central nervous system (CNS) of Tph2
 /  and Tph2-
heterozygous (Tph2
þ/ ) mice, and investigated the conse-
quence of complete and partial central serotonin depletion on
anxiety, aggression and depression-like behavior.
Materials and methods
Animals. All animal procedures were in accordance with
the ethical principles and guidelines for care and use of
laboratory animals adopted by German local authorities
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Mice were maintained in individually ventilated cages,
34 19 13cm (Tecniplast Deutschland, Hohenpeissen-
berg, Germany) under a standard light/dark cycle from 7 am
to 7 pm, with free access to standard chow (0.25% sodium,
SSNIFF Spezialita ¨ten, Soest, Germany) and drinking water
ad libitum.
To obtain Tph2 gene-deleted mice on a pure genetic
background, heterozygous Tph2-deﬁcient animals on C57Bl/
6 background (6th generation)
8 were bred for further four
generations to C57Bl/6 mice (Charles River, Sulzfeld,
Germany). All experiments have been performed in adult
(18–22 weeks old) F10 C57Bl/6 Tph2
 / , Tph2
þ/  and wild-
type (Tph2
þ/þ) male mice. To generate animals of the three
above-mentionedgenotypesTph2
þ/ femaleswerebredwith
Tph2
 /  or Tph2
þ/þ male mice. Genotyping was performed
using PCR with primer TPH34 (50-AGC TGA GGC AGA CAG
AAA GG-30), TPH54 (50-CCA AAG AGC TAC TCG ACC TAC
G-30) and Neo3 (50-CTG CGC TGA CAG CCG GAA CAC-30).
Mice were single housed starting at 10–12 weeks of age as
Tph2
 /  males are highly aggressive and cannot be kept in
groups. In order to avoid differences due to single-housing
condition Tph2
þ/  and Tph2
þ/þ were single housed as well
at least 4 weeks before experiments.
Group-housed (ﬁve mice per cage) 23–25g male mice on
FVB/N background were used as intruders in the resident–
intruder paradigm.
Behavioral assessment. Behavioral testing was performed
during the light cycle between 1 and 5 pm, with exception of
tail suspension test (TST), which was performed during the
dark cycle. In all experiments mice were habituated at least
for one week to the experimental room. During this time
handling of animals was done by the same experimenter who
performed the tests. One batch of animals was used for the
marble burying test (MBT) and was afterwards tested in the
elevated plus maze (EPM) test with a 1 week interval
between the two experiments. Another batch of animals was
tested ﬁrst in the novelty-suppressed feeding test (NSF), and
1 week later in the resident–intruder test (RI). Mice tested
ﬁrst in the open ﬁeld were then examined in the forced swim
test (FST). For the TST independent cohorts of naı ¨ve
animals was used. Before, TST mice were kept 9 weeks
under reversed dark–light cycle, with the light off at 10 am.
Mouse behavior was video recorded (Panasonic camera
HDC TM700, Hamburg, Germany) for subsequent ofﬂine
analyses by the experimenter. For analysis of EPM and OF
data Biobserve software (Viewer
2 version 2.2.0.91,
BIOBSERVE GmbH, Bonn, Germany) was used. In MBT,
activity was measured by InfraMot (TSE systems, Bad
Homburg Germany). In all experiments, the observer was
blinded to the genotype.
Open ﬁeld. A large arena (50 50cm) under low illumination
(30 Lux) was used as an OF to measure locomotor activity.
Each mouse was placed into the arena facing the middle of
the wall and its activity was measured during 10min. The
total distance traveled, time spent in the center and near the
walls were calculated.
Elevated plus maze. The EPM test is based on the inborn
aversion of rodents to open, bright illuminated spaces.
27 The
maze consisted of two open arms (30 5cm) and two closed
arms (30 5cm) that were enclosed by a sidewall on all
edges (height 15cm). Mice were placed in the center
of the maze (central platform) facing the closed arm. Total
arm entries, percent of entries into the open arm ((open-arm
enteries/total arm enteries) 100) and time spent in
open arms ((open arms/total session duration) 100)
were quantiﬁed during 10min test. Arm entry was only
deﬁned when an animal (the mouse mass center) was at
least 3cm on an arm to differentiate entries from stretched
attend postures into the arms.
Marble-burying test. Marble burying is a common test for
validating anxiolytic effect of drugs.
28 The test was
conducted in a new cage (equally sized and illuminated as
the home cage) with evenly spaced 15 clear glass marbles
(20mm diameter) in 5cm of sawdust. During the test mice
had access to food and water, and the test cage was covered
with a metal grid. After 30min the test was terminated by
removing the mouse and the number of buried marbles
was counted. A marble was scored as buried if more than
two-thirds of it was covered with sawdust. During the test
locomotor activity was evaluated by InfraMot (TSE systems).
Novelty-suppressed feeding. This test is based on a
provoked conﬂict between the fear of mice to enter bright
illuminated spaces and food seeking induced by hunger.
29,30
Animals were food deprived 23h before testing. On the test
day after placing mice into a novel home cage for 30min,
they were introduced into a new brightly illuminated test
environment (cage 42 25 18cm) where a single food
pellet was centrally placed. After the ﬁrst feeding event
animals were returned to their home cages where they were
allowed to eat pre-weighed food over a period of 5min.
Latency to the ﬁrst eating episode (time between mouse
introduction to arena with food pellet in the middle and the
ﬁrst feeding event) was used as an index of induced anxiety-
like behavior. The amount of food consumed in the home
cage provided a measure of appetitive drive.
Forced swim test. The FST, as originally described by
Porsolt,
31 assesses the tendency to give up attempting to
escape from an unpleasant environment, whereby fewer
attempts are interpreted as behavioral despair. The
apparatus was a plastic beaker (17.5cm diameter, 24cm
high), ﬁlled with water (24–261C) to a height of 18cm. The
time mice spent ﬂoating on the water (immobility time, sec)
during 6min as well as latency (sec) to the ﬁrst immobility
episode were manually observed. A mouse was judged to be
immobile when it ceased struggling and remained ﬂoating
motionless in water, making only those movements
necessary to keep its head above water. Swimming was
deﬁned as vigorous movements with forepaws breaking the
surface of the water.
Tail suspension test. The TST is another learned helpless-
ness paradigm where animals cannot escape from an
unpleasant situation. A reduction in struggling behavior
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immobility) is interpreted as a reduction in intrinsic motivation
to escape the situation. Mice were suspended by the tail
using an adhesive tape to a platform. The latency to the ﬁrst
immobility episode and the duration of immobility over a
6min period were continually manually measured. An animal
was rated as immobile when there was no movement of the
head, extremities or the torso.
Resident–intruder test. The RI test is based on the territory
defensive behavior against unfamiliar intruding conspeciﬁcs.
32
Each single-housed resident male was confronted in its home
cage by a group-housed (ﬁve mice per cage) intruder male
FVB/N mouse for 10min. Each intruder mouse was used only
once to avoid submissive/dominance effects after ﬁrst
interaction. Behavioral interactions during each confrontation
were recorded and subsequently scored by an observer.
Latency to the ﬁrst attack, total amount of attacks and
cumulative duration of attacks were analyzed.
Neurochemical assessments. To prepare brains for high-
performance liquid chromatography (HPLC) analysis, animals
were anesthetized by intraperitoneal ketamine (100mgkg
–1)
and xylazine (10mgkg
–1) injection. Animals were tran-
scardially perfused with phosphate-buffered saline containing
300Uml
–1 heparin (Braun, Melsungen, Germany) to remove
the blood, containing peripheral 5-HT. Brains were removed,
weighed and snap-frozen on dry ice. For the determination
of serotonin and its metabolites, frozen tissues were
homogenized in lysis buffer containing 10mM ascorbic acid
and 1.8% perchloric acid, centrifuged for 30min at 20000g,
41C, and the supernatant was used for HPLC measurement.
Tissue levels of 5-HTP, 5-HT and its metabolite 5-HIAA were
analyzed using high sensitive HPLC with ﬂuorometric
detection (Shimadzu, Tokyo, Japan).
33 Sample separation
takes place at 201C on a C18 reversed-phase column (OTU
LipoMareC18, AppliChrom Application & Chromatography,
Oranienburg, Germany) using a 10mM potassium phosphate
buffer, pH 5.0, containing 5% methanol with a ﬂow rate of
2mlmin
–1. Fluorescence of 5-HTP and 5-HT is excited at
295nm and measured at 345nm. For the evaluation of
serotonin synthesis in vivo animals were injected intra-
peritoneally with 100mgkg
–1 of aromatic amino acid decar-
boxylase inhibitor 3-hydroxybenzylhydrazine dihydrochloride
(NSD-1015, CatNr. 54880, Sigma-Aldrich, Munich, Germany)
1h before brain dissection. Amounts of 5-HT, 5-HTP and
5-HIAA were normalized to the wet tissue weight for
statistical analysis. Calculation of substance levels was
based on external standard values.
Real-time–PCR analysis. For real-time–PCR (RT–PCR)
analysis animals were ﬁrst decapitated, and brains were
promptly removed and snap-frozen on dry ice. RNA from the
whole brain was extracted with Trizol reagent (15596-018
Invitrogen, Darmstadt, Germany), and residual genomic DNA
was removed by DNase I treatment (DNA ampliﬁcation
grade, Sigma-Aldrich). RNA was reverse transcribed using
random hexamers and modiﬁed Moloney murine leukemia
virus reverse transcriptase (Superscript II, Invitrogen)
according to the manufacturer’s protocol. RT–PCR was run
in a technical triplicate using SYBR green reagent (Qiagen,
Hilden, Germany) in a 384-well plate format (fast RT–PCR
system 7900HT, Applied Biosystems, Darmstadt, Germany).
The expression of the Tph2 gene was quantiﬁed using
RT
2 quantitative PCR primer assay (PPM27894A-200
SABioscience, Hilden, Germany). Tph2 expression was nor-
malized to TATA-binding protein (TBP) mRNA expression
(primers: forward 50-CCC TAT CAC TCC TGC CAC ACC-30,
reverse 50-CGA AGT GCA ATG GTCTTT AGG TC-30). The
method of Livak and Schmittgen
34 was applied to compare
gene expression levels between groups, using the equation
2
 DDCT.
Statistics. Results are expressed as mean±s.e.m.
Statistical analysis was performed by unpaired Student’s
t-test and by one way ANOVA with Bonferroni’s correction as
a post-hoc test for multiple comparisons (PRISM, GraphPad,
San Diego, CA, USA). Po0.05 was considered to be
signiﬁcant.
Results
Tph2 expression and serotonin levels in Tph2
 / 
mice. We ﬁrst evaluated the amount of Tph2 transcripts in
the brains of Tph2
þ/  and Tph2
þ/þ mice, containing one
and two copies of the Tph2 gene, respectively. RT–PCR
showed a 50% reduction in Tph2 gene expression in the
whole brain of Tph2
þ/  mice in comparison with Tph2
þ/þ
mice (Figure 1a). We next measured the amount of serotonin
and its degradation product, 5-HIAA, in the whole brain of
Tph2
 / , Tph2
þ/  and Tph2
þ/þ mice by HPLC. Tph2
 / 
mice contained o2% of Tph2
þ/þ 5-HT level and no
detectable 5-HIAA in the brain (Figure 1b, Table 1),
conﬁrming previous results.
8 However, only around 10%
reduction in brain serotonin levels was observed in Tph2
þ/ 
in comparison with Tph2
þ/þ mice, whereas the level of 5-HT
degradation product, 5-HIAA, was reduced nearly by half in
Tph2
þ/  (Figure 1b, Table 1). We further evaluated the 5-HT
synthesis rate in Tph2
 / , Tph2
þ/  and Tph2
þ/þ mice by
blocking conversion of the 5-HTP to 5-HT by the aromatic
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Figure 1 Tph2 expression and serotonin synthesis in Tph2
 /  mice. (a) RT–
PCR analysis of Tph2 expression in the brain. AU, arbitrary units. **Po0.01,
Student’s t-test. (b) 5-HT level in the whole brain (HPLC measurement). Tph2
þ/þ
5-HT level is taken as 100%. (c) 5-HTP level in the whole brain 1h after NSD
administration (100mgkg
–1, intraperitoneally) (HPLC measurement). Tph2
þ/þ
5-HTP level is taken as 100%. Data are shown as means±s.e.m., n¼6.
***Po0.001, **Po0.01 vs Tph2
þ/þ;
yyyPo0.001 vs Tph2
þ/ , one-way
ANOVA with Bonferroni correction. ANOVA, analysis of variance; HPLC, high-
performance liquid chromatography; 5-HT, 5-hydroxytryptamine; 5-HTP,
5-hydroxytryptophan.
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decrease in accumulation of 5-HTP was observed in
Tph2
þ/  in comparison with Tph2
þ/þ mice (Figure 1c,
Table 1). As expected, Tph2
 /  mice accumulated o2% of
5-HTP compared with Tph2
þ/þ (Figure 1c, Table 1).
Anxiety-like behavior in Tph2
 /  mice. We ﬁrst evaluated
overall activity of Tph2
 /  mice in the OF under low
illumination conditions. Tph2
 /  mice did not show any
difference in locomotor activity in comparison with Tph2
þ/ 
and Tph2
þ/þ mice (Figure 2a).
In EPM, Tph2
 /  mice spent signiﬁcantly more time in the
open arms than Tph2
þ/þ and Tph2
þ/  (P¼0.0161 and
P¼0.0133, respectively) (Figure 2c). Tph2
 /  mice also
exhibited twice the amount of open-arm entries compared
with Tph2
þ/þ (P¼0.0026 vs Tph2
þ/þ, P¼0.0054 vs
Tph2
þ/ ) (Figure 2d). However, total arm entries and total
distance traveled were comparable between mice of all three
genotypes (Figure 2b). Analysis of locomotion in the EPM
over time showed that Tph2
 /  mice extensively explored the
brightest illuminated part of the open arms already during the
ﬁrst 5min of testing, whereas Tph2
þ/þ animals did not enter
thedistalpartsoftheopenarmsduringthewhole10minofthe
test. Tph2
þ/  mice did not show any signiﬁcant difference
compared with Tph2
þ/þ mice neither in the total time spentin
open arms nor in the open-arm entries (Figure 2c and d).
The amount of marbles buried by Tph2
 /  mice in the MBT
was signiﬁcantly lower than that of Tph2
þ/þ and Tph2
þ/ 
animals (P¼0.0199 and Po0.0001, respectively)
(Figure 2e). Interestingly, the general activity of Tph2
 / 
animals during this test was almost twofold higher than that of
Tph2
þ/þ (P¼0.0046) (Figure 2f). There was no signiﬁcant
difference in the percentage of marbles buried by Tph2
þ/ 
mice compared with Tph2
þ/þ mice (Figure 2e). However,
Tph2
þ/  showed an intermediate activity, signiﬁcantly differ-
ent from both Tph2
 /  and Tph2
þ/þ mice (P¼0.009 and
P¼0.023, respectively) (Figure 2f).
In the NSF task, Tph2
 /  mice needed less time to reach
and start eating the food pellet in the center of the arena
compared with Tph2
þ/þ and Tph2
þ/  (P¼0.002 and
P¼0.017, respectively) (Figure 2g). Food consumption,
evaluatedduring5minfollowingthetestdidnotdifferbetween
the genotypes (Figure 2h). Tph2
þ/  mice did not show a
signiﬁcant difference in the latency to reach and start eating
the food in comparison with both, Tph2
þ/þ and Tph2
 / 
(Figure 2g and h).
Depression-like behavior in Tph2
 /  mice. In the FST,
Tph2
þ/  mice did not show any signiﬁcant difference in
comparison with Tph2
þ/þ in the total immobility time or the
latency to the ﬁrst immobility episode, whereas Tph2
 /  mice
demonstrated reduced struggling behavior (Figure 3). They
spent less time swimming until the ﬁrst immobility episode
(P¼0.0001) (Figure 3a) and stayed longer immobile com-
pared with Tph2
þ/ and Tph2
þ/þ littermates (P¼0.005, in
comparison with both genotypes) (Figure 3b). Moreover,
Tph2
 /  mice showed an increase in immobility time during
each single 2min episode compared with Tph2
þ/þmice
(Figure 3b). In the TST no signiﬁcant differences between
genotypes could be found neither in the latency to immobility,
nor in the struggling time (Figure 3c and d).
Aggressive behavior in Tph2
 /  mice. In the RI test,
Tph2
 /  mice attacked the intruder almost six times faster
than Tph2
þ/þ mice (P¼0.0002) (Figure 4a). Furthermore,
the number of attacks and the cumulative attack duration in
the Tph2
 /  vs Tph2
þ/þ group were elevated sevenfold
(P¼0.0014 and P¼0.01, respectively) (Figure 4b and c).
A qualitative analysis of attacks revealed a striking difference
between Tph2
 /  and Tph2
þ/þ mice: within 5min of the
test all mutant animals displayed aggressive bouts, while
only 22% of Tph2
þ/þ mice showed such behavior.
Though Tph2
þ/  mice tended to show an intermediate
state of aggressive behavior between Tph2
 /  and Tph2
þ/þ
mice, neither the differences in the ﬁrst attack latency nor the
number of attacks between Tph2
þ/  and Tph2
þ/þ mice
were signiﬁcantly different (Figure 4a and b).
Discussion
Although the implication of brain serotonin in animal behavior
has been recognized already in the last century, most of the
studies were conducted using pharmacological or genetic
inhibition of serotonin reuptake and 5-HT receptors. However,
the role of serotonin per se in these studies was not completely
clariﬁed,becausenosuitableanimalmodelwasavailableyet.In
this study, we used mice deﬁcient in brain serotonin synthesis
on a pure genetic background to evaluate the consequences of
complete absence of this neurotransmitter in the CNS on
aggression-, depression- and anxiety-like behavior.
A role of serotonin in the etiology of depressive disorders
was suggested more than 50 years ago.
35 Later on,
formulation of the monoaminergic theory of depression led
to the development of antidepressive drugs, which increase
the monoaminergic activity.
36 Moreover, severely depressed
patients treated with Trp or 5-HTP show symptomatic
improvement,
37,38 whereas, giving Trp-free diet to depressed
Table 1 Serotonin, 5-HIAA and 5-HTP in the brains of Tph2-deﬁcient mice
5-HT (pgmg
–1) 5-HIAA (pgmg
–1) 5-HTP (pgmg
–1) 5-HTP/NSD (pgmg
–1)
Tph2
+/+ 753.0±16.3 366.3±34.9 3.7±0.3 329.1±14.0
Tph2
+/  655.6±24.1** 217.0±11.7* 2.0±0.2* 266.7±7.1*
Tph2
 /  13.6±1.0*
,*** 0.0±0.0*
,*** 0.0±0.0*
,*** 5.7±0.3*
,***
Abbreviations: 5-HT, 5-hydroxytryptamine; 5-HTP, 5-hydroxytryptophan; 5-HIAA, 5-hydroxyindoleacetic acid; NSD, 3-hydroxybenzylhydrazine dihydrochloride.
Serotonin (5-HT), 5-HTP and 5-HIAA levels were measured by HPLC in whole brain lysates. Serotonin synthesis rate was evaluated by the accumulation of 5-HTP in
the brain during 1h after administration of the AADC inhibitor, NSD (5-HTP/NSD column). Values are normalized to mg of wet brain tissue. Data are presented as
means±s.e.m., n¼6. *Po0.001; **Po0.01 vs Tph2
+/+; ***Po0.001 vs Tph2
+/  (one-way ANOVA with Bonferroni’s correction).
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antidepressants.
39,40
In our experiments, mice depleted in brain serotonin
exhibited a lack of motivation to struggle in the FST that
canbeinterpretedasadepression-likephenotype,supporting
the monoaminergic theory of depression. There is some
discrepancy regarding this phenotype between our results
and recent data showing a slight antidepressive effect in
Tph2
 /  mice on the second day of FST.
10 These conﬂicting
ﬁndings could be due to several reasons, such as different
analysis methods — automated
10 vs manual (our study)
41 —
or the 2-day FST protocol,
10 which is commonly used for
identifying a depressive state in rats vs the 1-day protocol
usually performed for mice.
42,43 Moreover, the study of
depression-like behavior by Savelieva et al.
10 was performed
ab c
+/+ +/- -/- +/+ +/- -/- +/+ +/- -/-
0
150
300
450
600
***
§§
l
a
t
e
n
c
y
 
t
o
 
t
h
e
 
f
i
r
s
t
 
a
t
t
a
c
k
,
 
s
e
c
0
10
20
30
40
**
§
a
m
o
u
n
t
 
o
f
 
a
t
t
a
c
k
s
,
 
n
u
m
b
e
r
0
20
40
60
80
100
120
**
§
c
u
m
u
l
a
t
i
v
e
 
a
t
t
a
c
k
 
d
u
r
a
t
i
o
n
,
 
s
e
c
Figure 4 Aggressive behavior in Tph2
 /  mice. Resident–intruder test: (a)
Attack latency: time between the introduction of intruder and the ﬁrst attack of the
resident. (b) Total amount of attacks by the resident. (c) Cumulative attack duration
during 10min tested time. Residents were Tph2
 /  (n¼9), Tph2
þ/  (n¼8),
Tph2
þ/þ (n¼7). Data are shown as means±s.e.m., n¼8. ***Po0.001,
**Po0.01 vs Tph2
þ/þ;
yPo0.05,
yyPo0.01 vs Tph2
þ/ , one-way ANOVA with
Bonferroni correction. ANOVA, analysis of variance.
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Figure 2 Locomotor activity and anxiety-like behavior in Tph2
 /  mice. Open
ﬁeld: (a) Total distance traveled. Elevated plus maze: (b) Activity: total number of
entries to closed and open arms. (c) Percentage of entries to open arms: entries to
open arm/total arm entries. (d) Total time spent in open arms. Marble burying test:
(e) Percentage of buried marbles: buried/introduced amount of marbles. (f)
Locomotor activity during MBT. Novelty supressed feeding: (g) Latency to feed. (h)
Consumed amount of food during 5min after reaching the food pellet. (a–f):
Tph2
 /  n¼10, Tph2
þ/  and Tph2
þ/þ n¼12; (g, h): Tph2
 /  n¼11,
Tph2
þ/  n¼13,Tph2
þ/þ n¼10.Data areshownasmeans±s.e.m.**Po0.01,
*Po0.05 vs Tph2
þ/þ;
yyyPo0.001,
yyPo0.01,
yPo0.05 vs Tph2
þ/ , one-way
ANOVA with Bonferroni correction. ANOVA, analysis of variance.
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Figure 3 Depression-like behavior in Tph2
 /  mice. Forced swim test: (a)
Latencyto theﬁrstimmobilityepisode.(b)Immobilitytimeduring2min intervalsand
the whole 6min of tested period. Tail suspension test: (c) Latency to the ﬁrst
immobility episode. (d) Immobility time during 6min of tested period. Data are
shown as means±s.e.m., (a, b): n¼10, (c, d): n¼9. ***Po0.001, **Po0.01,
*Po0.05 vs Tph2
þ/þ;
yyyPo0.001,
yyPo0.01,
yPo0.05 vs Tph2
þ/ , one-way
ANOVA with Bonferroni correction. ANOVA, analysis of variance.
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mayhavemaskedthebehavioraleffectofTph2geneablation.
Evaluation of mouse behavior in another widely used
paradigm, the TST, did not reveal a depression-like pheno-
type in Tph2
 /  mice. This ﬁnding is consistent with previous
studies showing that depletion of serotonin using p-chloro-
phenylalanine (PCPA) does not change the outcome of the
TST, whereas inhibition of catecholamine synthesis has a
prodepressive effect in this test.
44 Also in the ﬁrst description
of Tph2
 /  mice
10 no differences in the TST were observed at
the ﬁrst day of experiment. Interestingly, there are reports that
show an increased immobility time in the TST in another
genetic model of central serotonin depletion — heterozygous
VMAT2-knockout mice.
45 However, in these mice levels of
other neurotransmitters are also changed and, therefore, the
alteredbehaviorinTSTcouldnotbeinterpretedasonly dueto
the depletion of central serotonin. Surprisingly, when VMAT2
was ablated only in SERT-positive neurons, the behavior in
TST was reversed: VMAT2
SERT-Cre mice showed a clear
antidepressive phenotype in the TST.
46 However, these
animals were on a mixed genetic background that may have
veiled the effect of central serotonin ablation.
Although both tests, TST and FST, are widely used for the
screening of antidepressants, the validity of these tasks to
evaluate symptoms of intrinsic depressive behavior is not so
clear.
47 Moreover, the sensitivity of these two tests to
pharmacological drugs is not identical, indicating that different
neurochemical pathways may mediate the performance in
these tasks.
48 Additionally, mice being in two different
inescapable situations (wet conditions in FST and dry in
TST) could use different strategies to struggle. Accordingly,
the direction of alterations in depression-like behavior
observed in several hyposerotonergic models was not
consistent across the studies and even controversial between
the two tests (TST and FST) in frames of the same
study.
10,46,49 We observed a clear depression-like phenotype
in FST, which was also highly reproducible in our hands—we
obtained the same results in two independent experiments
(data not shown). However, we could not conﬁrm the
depression-like phenotype of Tph2
 /  mice in the TST. We
cannot exclude that this phenotype was masked due to the
performance of the test during the dark cycle. Further studies
are required to clarify the impact of the dark–light cycle on the
depression-like behavior in Tph2
 /  animals.
Several previous studies failed to detect any drastic
alteration in depression-like behavior in models of serotonin
depletion after PCPA treatment.
50–52 The clear depression-
like phenotype observed in the FST in Tph2
 /  mice can be a
consequence of a life-long depletion in serotonergic transduc-
tion vs short-term effects of PCPA. In this respect, it is
interesting to note, that mice prenatally exposed to PCPA
show increased depression-related behavior in FST and TST
and decreased anxiety.
53,54 Due to the extreme aggressive-
ness of Tph2
 /  mice, animals used in our study could not be
kept in groups and were single housed starting 10–12 weeks
of age. We can also not exclude that alterations observed in
the FST were primed by the prolonged single housing of
animals, which may have had more pronounced conse-
quencesin Tph2
 /  animals owingto their higher sensibility to
isolation. In addition, hormonal changes resulting from
exaggerated aggressiveness or higher sensitivity to stress,
aswellasthereducedfatcontentinTph2
 / animals
10,12(our
unpublished data) may have had an impact on the outcome of
the FST.
As any of the behavior tests used in this study could be
inﬂuenced by changed activity, we examined whether
Tph2
 /  mice have any alterations in locomotion. Neither
activity in the OF (new environment), nor home cage activity
measured by telemetry recording
8 or InfraMot system (TSE
Systems GmbH, data not shown) were different between
Tph2
 /  mice and control animals.
Serotonin has been postulated to have a role in aggres-
sion.
55,56 Low cerebrospinal 5-HIAA was correlated with
elevated aggression in humans
26,57,58 and monkeys.
59
Furthermore, low-Trp diet resulted in increased aggressive
behavior in humans,
60 whereas Trp-enriched diet initiated a
reduction of physical aggression in subjects that had a history
of elevated aggression.
61 Several genetic variations in
serotonergic genes have been linked to impulsive aggression
in humans.
62,63 Moreover, a positive correlation between low
serotonin release and increased aggression was conﬁrmed by
microdialysis in freely moving animals during the RI test.
64,65
Inhibition of serotonin synthesis in rats led to increased
aggressiveness, whereas enhancement of serotonin trans-
mission suppressed aggressive behavior.
66 Our study re-
vealed that central serotonin deﬁciency led to highly increased
aggressive behavior in mice. Interestingly, this phenotype was
observed not only in males, but also in Tph2
 /  females.
8
Thus, our model provides strong evidence for increased
aggression as a consequence of complete serotonin deﬁ-
ciency in the CNS being in line with two recently published
hyposerotonergic animal models, TPH2 R439H knockin mice,
bearing a single-nucleotide mutation, equivalent to a rare
humanvariant (R441H) identiﬁed in depressedpatients,
49 and
Pet-1 deﬁcient animals, which lack most serotonergic neu-
rons.
62,67 Altogether, these data argue for a direct correlation
between the serotonin content in the brain and the level of
aggression.
It was recently reported that the absence of brain serotonin
leads to increased male–male mounting behavior in a
30min social interactions task.
9 This phenotype was not
prominent during 10min of the resident–intruder test per-
formed in our study. Moreover, in several cases we had
to interrupt the test due to the extreme aggressiveness of
Tph2
 /  animals. It can not be excluded that defensive
behavior of serotonin-deﬁcient animals was misinterpreted in
the study of Liu et al.
9
The behavioral evaluation performed in this study showed
thatTph2
 /  micehavedecreasedlevelsofaversivebehavior
in approach-avoidance-conﬂict tests, correlating with the
hypothesis that enhanced serotonergic transmission in the
brain facilitates anxiety, whereas a decrease in extracellular
5-HT leads to reduced anxious behavior. This hypothesis,
formulated in early 1970s
68 was further reﬁned using animal
models with 5-HT depletion by serotonin synthesis inhibition
or lesions of serotonergic neurons.
69–72 Furthermore, studies
in SERT overexpressing and SERT-deﬁcient mice,
73–75 in
5-HT1a-deﬁcient animals,
76 as well as in very recently
published hyposerotonergic mouse models including Lmx1b-,
Pet1- or VMAT2-deﬁcient animals
46,77,78 correlate with this
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type, observed in the EPM and NSF tests, the results of the
MBT poorly correlate with literature data from other genetic
models affecting the serotonergic system.
10,62,79 We suppose
that opposite effects observed in our study originate mostly
from the differences in the genetic background (pure C57Bl/6
used by us vs mixed in other studies)—a factor which may
strongly affect serotonin-related behavior, as already shown in
SERT-knockout mice.
74 On the other hand, the experimental
setup used by us was not identical to the one of other studies:
the protocols differ in several aspects, such as amount of
marbles, cage parameters and test conditions. Moreover, we
cannot exclude that increased locomotion, unexpectedly
observed during MBT and not reported in other studies, had
an impact on results of this test in our experiments.
There is a vast amount of data about the contribution of
molecular variants of TPH2 to psychiatric disorders in hu-
mans.
15 Interestingly, one single-point mutation (R441H)
found in a human cohort of late-onset depression was shown
to markedly decrease activity of TPH2 and central serotonin
level.
80 A genetic mouse model carrying a single-point
mutation (R439H) in Tph2, analogous to this human mutation
exhibit signiﬁcantly decreased tissue levels and synthesis
rates of 5-HT in the brain, and shows pronounced depression-
like behavior in TST, as well as increased aggression.
49 To
check whether reduction in Tph2 gene copy number may also
signiﬁcantly inﬂuence behavior in mice, we evaluated the
phenotype of Tph2
þ/  animals. Quantiﬁcation of Tph2 mRNA
level revealed a decrease in Tph2 expression by half,
suggesting that in wild-type animals both Tph2 alleles are
functional and do not undergo epigenetic modiﬁcation.
Regardless, the 50% decrease in Tph2 transcriptional activity,
only a 10% reduction in 5-HT level was observed. We missed
this difference in our previous study,
8 probably because it was
masked by the more heterogeneous background of these
animals.Suchaslightdecreasecanbepartiallyexplainedbya
reducedturnoverofserotoninbyMAOinTph2
þ/ mice,thatis
evident from the reduced level of the serotonin degradation
product 5-HIAA (Table 1). However surprisingly, evaluation of
5-HT synthesis rate also revealed only a 20% decrease in
Tph2
þ/  animals, which probably reﬂects the limited avail-
ability of Trp in the brain.
81,82 Nevertheless, the 10% decrease
in brain 5-HT was not sufﬁcient to alter mouse behavior:
Tph2
þ/  werenotdifferent from Tph2
þ/þ mice in aggression,
anxiety or depression-like behavior. Similar effects were
recently observed in mice carrying the C1473G mutation in
the Tph2 gene. This mutation resulted in a decreased 5-HT
synthesis rate, but hardly changed serotonin content in the
brain,anddidnotaffectthebehaviorindepressionandanxiety
paradigms.
83,84TheseﬁndingssuggestthatalackofoneTph2
allele alone is not sufﬁcient to modulate aggression and
depression-like behavior and therefore is unlikely to be of
physiologicalsigniﬁcance.However,itcannotbeexcludedthat
geneticvariationinotherserotonin-relatedgenes,restrictionor
alterations in nutrition, medical treatment and epigenetic
modiﬁcations acquired during lifespan, may unmask a critical
role of TPH2 hypo-expression in the development of patholo-
gical symptoms in human.
Taken together, using Tph2
 /  mice on a pure genetic
background, we provide strong evidence that central
serotonin deﬁciency leads to exaggerated aggression and
decreased anxiety and conﬁrm thatour animal model is useful
to draw unequivocal conclusions about the physiological
signiﬁcance of this neurotransmitter.
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